PGI laboratory designing

Tribune News Service Chandigarh, March 15 As the disease burden of Covid-19 continues to increase in the country with a greater number of cases being reported, the Experimental Pharmacology Laboratory (EPL), Department of Pharmacology, PGIMER, has taken initiatives to confront...

Tribune News Service

Updated At : 12:03 PM Mar 16, 2020 IST

Tribune News Service

Chandigarh, March 15

As the disease burden of Covid-19 continues to increase in the country with a greater number of cases being reported, the Experimental Pharmacology Laboratory (EPL), Department of Pharmacology, PGIMER, has taken initiatives to confront this problem by designing new drugs against the virus.

Prof Bikash Medhi, Department of Pharmacology, PGIMER, Chandigarh, and his team comprising Dr Phulen Sarma, Nishant Sekhar, Manisha Prajapat, Dr Pramod Avti, Dr Ajay Prakash, Hardeep Kaur, Dr Subodh Kumar, Dr Harish Kumar and Dr Seema Bansal have identified few potential targets (nucleocapsid protein, protease enzyme, E protein, M Protein, Spike protein), upon which in-silico drug designing was carried out and few important hits were identified in the past two months.

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is run by a trust comprising five eminent persons as trustees.

The Tribune, the largest selling English daily in North India, publishes news and views without any bias or prejudice of any kind. Restraint and moderation, rather than agitational language and partisanship, are the hallmarks of the newspaper. It is an independent newspaper in the real sense of the term.

The Tribune has two sister publications, Punjabi Tribune (in Punjabi) and Dainik Tribune (in Hindi).

Remembering Sardar Dyal Singh Majithia

Designed and developed by : SORTD

Suggested Articles